Number of the records: 1
C-peptid
SYS d002096 LBL 00000cz--a2200000n--4500 005 20250606214534.3 008 920416|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a D06.472.699.587.200.500.250 065 $a D12.644.548.586.200.500.250 066 $a 01 $c 03 150 $a C-peptid $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DE $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UL $x UR $2 slo 450 $w v $a Proinsulin C-Peptide $2 eng 450 $w v $a C-peptid proinzulínový $2 slo 450 $w v $a C peptid spájajúci $2 slo 665 $a 84(77); was see under PEPTIDES 1977-83 $2 eng 665 $a Peptides (1973-1976) $2 eng 665 $a Proinsulin (1975-1976) $2 eng 680 9-
$i The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. $2 eng 680 $a from proinsulin only: not for peptide fragments from other proteins ( = PEPTIDE FRAGMENTS) $2 eng 750 -2
$a C-Peptide $2 eng 980 $x M
Number of the records: 1